Skip to main content

Akebia Therapeutics, Inc.

AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001517022

No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Akebia Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
124
−9 vs. Q4 2021
Shares held
81.2M
−15.6M (−16.1%) vs. Q4 2021
Total value
$58.3M
−$160.4M (−73.3%) vs. Q4 2021
New holders
17
40 more added
Sold out
26
43 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 124 institutions
Q1 2021: 145 institutionsQ2 2021: 139 institutionsQ3 2021: 127 institutionsQ4 2021: 133 institutionsQ1 2022: 124 institutionsQ2 2022: 97 institutionsQ3 2022: 90 institutionsQ4 2022: 75 institutionsQ1 2023: 65 institutionsQ2 2023: 79 institutionsQ3 2023: 76 institutionsQ4 2023: 87 institutionsQ1 2024: 114 institutionsQ2 2024: 103 institutionsQ3 2024: 114 institutionsQ4 2024: 121 institutionsQ1 2025: 143 institutionsQ2 2025: 158 institutionsQ3 2025: 177 institutionsQ4 2025: 166 institutionsQ1 2026: 171 institutionsQ2 2026: 170 institutions
Value heldQ1 2022: $58.3M
Q1 2021: $340.3MQ2 2021: $402.4MQ3 2021: $283.7MQ4 2021: $218.7MQ1 2022: $58.3MQ2 2022: $20.2MQ3 2022: $16.5MQ4 2022: $30.2MQ1 2023: $29.1MQ2 2023: $46.0MQ3 2023: $58.0MQ4 2023: $72.7MQ1 2024: $104.3MQ2 2024: $57.4MQ3 2024: $78.4MQ4 2024: $128.9MQ1 2025: $182.7MQ2 2025: $394.1MQ3 2025: $337.7MQ4 2025: $190.4MQ1 2026: $141.4MQ2 2026: $123.2M
Institutions holding AKBA and their total value by quarter
QuarterHoldersValue
Q2 2026170$123.2M
Q1 2026171$141.4M
Q4 2025166$190.4M
Q3 2025177$337.7M
Q2 2025158$394.1M
Q1 2025143$182.7M
Q4 2024121$128.9M
Q3 2024114$78.4M
Q2 2024103$57.4M
Q1 2024114$104.3M
Q4 202387$72.7M
Q3 202376$58.0M
Q2 202379$46.0M
Q1 202365$29.1M
Q4 202275$30.2M
Q3 202290$16.5M
Q2 202297$20.2M
Q1 2022124$58.3M
Q4 2021133$218.7M
Q3 2021127$283.7M
Q2 2021139$402.4M
Q1 2021145$340.3M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding AKBA in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Metropolitan Life Insurance Co11,718$8.41K0.00%−30,430−72.2%Reduced
Royal Bank of Canada10,837$8.00K0.00%−24,958−69.7%Reduced
Sonora Investment Management Group, LLC11,085$8.00K0.00%−2,000−15.3%Reduced
Ameritas Investment Partners, Inc.11,500$8.00K0.00%00.0%Unchanged
United Capital Financial Advisers, LLC10,299$7.00K0.00%+10,299New
Running Point Capital Advisors, LLC10,000$7.00K0.00%+10,000New
Great West Life Assurance Co7,428$6.00K0.00%00.0%Unchanged
AdvisorNet Financial, Inc5,000$4.00K0.00%+5,000New
Johnson Financial Group, Inc.3,984$3.00K0.00%+3,984New
Aquatic Capital Management LLC4,700$3.00K0.00%+4,700New
Macquarie Group Ltd3,370$2.00K0.00%00.0%Unchanged
Fifth Third Bancorp3,300$2.00K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.3,771$2.00K0.00%+1,900+101.5%Added
TD Waterhouse Canada Inc.1,553$1.26K0.00%+262+20.3%Added
Nisa Investment Advisors, LLC1,608$1.00K0.00%−354,600−99.5%Reduced
Advisor Group Holdings, Inc.963$1.00K0.00%00.0%Unchanged
EverSource Wealth Advisors, LLC1,250$1.00K0.00%00.0%Unchanged
Exane Derivatives471$3380.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec150$1080.00%00.0%Unchanged
Baldwin Brothers Inc561$00.00%00.0%Unchanged
Daiwa Securities Group Inc.316$00.00%00.0%Unchanged
Captrust Financial Advisors10$00.00%00.0%Unchanged
Focused Wealth Management, Inc65$00.00%00.0%Unchanged
Hexagon Capital Partners LLC186$00.00%00.0%Unchanged
Nantahala Capital Management, LLC0$00.00%−4,918,565−100.0%Sold out
Marshall Wace, LLP0$00.00%−4,475,138−100.0%Sold out
Woodline Partners LP0$00.00%−2,231,966−100.0%Sold out
Nuveen Asset Management, LLC0$00.00%−580,106−100.0%Sold out
PDT Partners, LLC0$00.00%−433,400−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−333,841−100.0%Sold out
Caption Management, LLC0$00.00%−210,000−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−158,507−100.0%Sold out
Twinbeech Capital LP0$00.00%−148,321−100.0%Sold out
Virginia Retirement Systems Et Al0$00.00%−111,800−100.0%Sold out
Two Sigma Investments, LP0$00.00%−97,174−100.0%Sold out
Engineers Gate Manager LP0$00.00%−80,072−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−76,324−100.0%Sold out
Alpine Global Management, LLC0$00.00%−54,999−100.0%Sold out
SG Americas Securities, LLC0$00.00%−43,176−100.0%Sold out
Blair William & Co0$00.00%−16,599−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−13,106−100.0%Sold out
Wolverine Trading, LLC0$00.00%−12,536−100.0%Sold out
Ameriprise Financial Inc0$00.00%−10,549−100.0%Sold out
AE Wealth Management LLC0$00.00%−10,300−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−2,004−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−1,630−100.0%Sold out
Signaturefd, LLC0$00.00%−811−100.0%Sold out
Truvestments Capital LLC0$00.00%−900−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−374−100.0%Sold out
PFS Partners, LLC0$00.00%−187−100.0%Sold out